Do you test ovarian cancer tumors for targetable biomarkers (e.g., HER2, folate receptor, MMR) at the time of primary diagnosis or at time of recurrence?
If you send it at the time of recurrence, do you try to send a new tissue sample or use archival slides from their primary surgery?
Community PollStarted
When do you test ovarian cancer for targetable biomarkers (folate receptor, HER2, etc.)?
7 physicians have voted
Join Mednetto vote and see how they answered.